LSI Europe

Our resource library contains thousands of insightful executive sessions from previous events, captivating photos, and the latest alumni news. Dive in today to prepare for your next LSI experience. Visit here: https://www.pinterest.com/pin/1108378158334634114

At LSI Europe ’25, one of the more revealing conversations was not about a single therapeutic area, product category, or financing milestone. It was about portfolio construction itself. In a debate session titled “Including Medtech, Biotech, or Healthtech in Your VC Thesis,” investors from TVM Capital Life Science, Canaan Partners, Santé Ventures, Brightlands Venture Partners, and Unorthodox Ventures offered a candid look at how they think about risk, timing, capital efficiency, and long-term returns across healthcare. For founders trying to understand what different investors actually want, the discussion provided a sharp window into how medtech venture capital firms are making decisions in a more disciplined market. Moderated by Luc Marengere of TVM Capital Life Science, the panel made one thing clear early: there is no single right way to build a healthcare investment strategy. Some firms continue to back medtech as a core pillar. Others have stepped away from it at the earliest sta...

The consumerization of healthcare is reshaping how patients interact with the medical system. As more people take a proactive approach to managing their health, medtech companies have a unique opportunity to harness patient behavior and drive real value. At LSI Europe ’24, a panel of industry experts gathered to discuss the evolving landscape of consumerization in medtech and the need to understand and target patient behaviors to enhance health outcomes. Visit here: https://www.flipgorilla.com/p/29362908924216102/show

Cross-border business development in medtech is rarely a straight line. Between regulatory complexity, reimbursement variability, cultural nuances, and market-specific needs, expanding into new regions requires more than a product—it demands a strategy. At a recent LSI medtech conference in Europe, panelists Eliane Schutte (Xeltis), Jeffrey Sirek (PRIA Healthcare), Pieter Wijffels (NLC Health Ventures), and Sabine Kapasi (Enira Consulting), led by moderator Ajay Nair (The Mullings Group), tackled the topic head-on. Drawing from firsthand experience across Europe, the United States, China, India, and the Middle East, they explored what it takes to succeed in cross-border business development—from diligence and IP to commercialization, licensing, and culture. Visit here for more details: https://www.lsieuropesummit.com/news/the-art-and-science-of-cross-border-business-development

Raising capital is always a challenge, but raising capital from family offices requires an entirely different playbook. That was the message from the LSI Europe ’24 panel, where entrepreneurs and investors broke down the unique advantages—and nuances—of working with family offices instead of traditional medtech venture capital. Moderated by Alexei Mlodinow, former CEO and co-founder of SIA, the conversation featured insights from Marie-Louise Little (TW Medical A/S), Tyler Wanke (Wanke Family Office), John Slump (Atraverse Medical), and Pablo Prieto (CG Health Ventures). Together, they offered a candid look at what it takes to earn trust, navigate timelines, and build relationships that can unlock transformational support for medtech companies. Visit here for more details:  https://www.lsieuropesummit.com/news/raising-capital-from-family-offices-a-playbook-for-founders